NP Life Sciences Health Industry Group Inc. SEC filings ACAT
NP Life Sciences Health Industry Group Inc. has 59 filings in SEC EDGAR's recent list, going back to Jul 9, 2019. Its latest annual report, Form 10-K, was filed on Apr 16, 2024 for the period ended Dec 31, 2023. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2023, covering the quarter ended Sep 30, 2023. The most recent current report (Form 8-K) was filed on Sep 8, 2022 (change in control, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 23, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 22, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 16, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 15, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 15, 2019 | Sep 30, 2019 |
Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Educational Services (SIC 8200)
- Listed as
- ACAT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Danville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1781726
- Former names
- GJ Culture Group US, Inc. (until Sep 29, 2022)
Other Services-Educational Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.